Cantel Medical Story

CMD -- USA Etf

USD 86.30 0.60 0.70%

Macroaxis Story

Cantel Medical Revenue Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Revenue Per Employee was at 248,554. The current year Average Assets is expected to grow to about 2.4 B, whereas Average Equity is forecasted to decline to about 677.3 M. As many investors are getting excited about proshares space, it is fair to digest Cantel Medical. We will analyze why it could be a much better year for Cantel Medical shareholders. Here I will also expose some primary fundamental factors affecting Cantel Medical's services, and outline how it will impact the outlook for investors this year.

Published over a month ago

View all stories for Cantel Medical | View All Stories

Is Cantel Medical (NYSE:CMD) ripping up shareholders?

The company reported the last year's revenue of 1.06 B. Total Income to common stockholders was 32.41 M with profit before taxes, overhead, and interest of 462.58 M.

And What about dividends?

A dividend is the distribution of a portion of Cantel Medical earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Cantel Medical dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Cantel one year expected dividend income is about $0.03 per share.

The current year Dividend Yield is expected to grow to 0.002211, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (4.3 M).

	Last Reported	Projected for 2021
Payment of Dividends and Other Cash Distributions	-4 M	-4.3 M
Dividend Yield	0.0018	0.002211
Dividends per Basic Common Share	0.12	0.12

Investing in stocks that pay dividends, such as etf of Cantel Medical, is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Cantel Medical must own a stock before its ex-dividend date to receive its next dividend.

This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Cantel Medical. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

How important is Cantel Medical's Liquidity

Cantel Medical financial leverage refers to using borrowed capital as a funding source to finance Cantel Medical ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Cantel Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Cantel Medical's total debt and its cash.

How Cantel utilizes its cash?

To perform a cash flow analysis of Cantel Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cantel Medical is receiving and how much cash it distributes out in a given period. The Cantel Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Cantel Medical Net Cash Flow from Operations is projected to increase significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at 157.39 Million

What did Cantel Medical file with SEC?

The SEC filings are financial statements or other formal documents of Cantel Medical that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database.

Please check here for more information.

Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Cantel shareholders may or may not be submitted as SEC does not always require it.

	1st of April 2021 Other Events	View
	10th of March 2021 Unclassified Corporate Event	View
	9th of March 2021 Financial Statements and Exhibits. Results of Operations and Financial Condition	View
	18th of December 2020 Submission of Matters to a Vote of Security Holders	View

Breaking it down

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cantel Medical has an asset utilization ratio of 152.62 percent. This indicates that the ETF is making $1.53 for each dollar of assets. An increasing asset utilization means that Cantel Medical is more efficient with each dollar of assets it utilizes for everyday operations.

Are Cantel Medical technical ratios showing a bounce back?

Latest potential upside is at 3.83. Cantel Medical has relatively low volatility with skewness of 4.67 and kurtosis of 30.9. However, we advise all investors to independently investigate Cantel Medical to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cantel Medical's etf risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cantel Medical's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Take On Cantel Medical

Although some other companies within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, Cantel Medical may offer a potential longer-term growth to shareholders. While some shareholders may not share our view, we believe that right now is not a good time to increase your holdings in Cantel. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Cantel Medical.

About Contributor

Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Cantel Medical. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC